Clinical Trial Update: SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin [Phase 4]

View source ↗

Summary

This update reports the completion of the Phase 4 SAMBA trial evaluating the sexual function and management of symptoms in men with benign prostatic hyperplasia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Uroxatral (Alfuzosin)

Snippet

Sponsor: Sanofi | Conditions: Prostatic Hyperplasia | Phase 4 | Status: COMPLETED